[
  {
    "ts": "2025-06-12T12:30:00+00:00",
    "headline": "Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp",
    "summary": "Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Onco",
    "url": "https://finance.yahoo.com/news/predictive-oncology-develops-functional-3d-123000214.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "992571c2-3eb1-38cc-8537-fb6147bfb6f3",
      "content": {
        "id": "992571c2-3eb1-38cc-8537-fb6147bfb6f3",
        "contentType": "STORY",
        "title": "Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp",
        "description": "",
        "summary": "Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Onco",
        "pubDate": "2025-06-12T12:30:00Z",
        "displayTime": "2025-06-12T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/9031d63fd27c35ddd86993f9374a98ad",
          "originalWidth": 2400,
          "originalHeight": 1256,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m7jhSK4v2OckdlE_OWNfwg--~B/aD0xMjU2O3c9MjQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/9031d63fd27c35ddd86993f9374a98ad.cf.webp",
              "width": 2400,
              "height": 1256,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kSJp9h44iIMthaHJsIsqsQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9031d63fd27c35ddd86993f9374a98ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/predictive-oncology-develops-functional-3d-123000214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/predictive-oncology-develops-functional-3d-123000214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            },
            {
              "symbol": "POAI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]